TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Adaptive Biotechnologies Stock

Adaptive Biotechnologies Stock

adaptivebiotech.comHealthcareFounded: 2009Funding to Date: $561.37MM

Adaptive Biotechnologies is a biotechnology company specializing immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.

Learn more about Adaptive Biotechnologies IPO
Register for Details

For more details on financing and valuation for Adaptive Biotechnologies, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Adaptive Biotechnologies.

Register Today

Team

Management Team

JULIE RUBINSTEIN
President
SEAN NOLAN
Chief Technical Officer
CHAD ROBINS
Chief Executive Officer, Co-founder
LANCE BALDO
Chief Medical Officer
HARLAN ROBINS, PHD
Chief Scientific Officer, Co-founder
CHAD COHEN
Chief Financial Officer

Board Members

PETER NEUPERT
Operating Partner at Health Evolution Partners
MIKE PELLINI, MD
MICHELLE GRIFFIN
Adaptive Biotechnologies
ANDRIS ZOLTNERS
Self
KEVIN CONROY
DAVID GOEL
Matrix Capital Management
CHAD ROBINS
Adaptive Biotechnologies
ERIC DOBMEIER
Adaptive Biotechnologies
ROBERT HERSHBERG, MD, PhD
Celgene

Other companies like Adaptive Biotechnologies in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Cytonics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Precision Neuroscience
Sector
Healthcare
 
 

News

Genomeweb 02/15/2022
Adaptive Biotechnologies Revenues Rise 26 Percent in Q4, 57 Percent in 2021
Fourth quarter sequencing revenue increased 81 percent to $23.1 million year over year, while development revenue dropped 15 percent to $14.9 million.
Genomeweb 08/13/2021
People in the News: New Appointments at BD, Adaptive Biotechnologies, ChromaCode, More
Genomeweb 05/05/2021
Adaptive Biotechnologies Q1 Revenues up 84 Percent, Beat Analyst Estimates

Trending Companies

Frequently Asked Questions